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Abstract
We bring together estimates of patterns of medical spending in all nine
countries considered in this issue – Canada, Denmark, England, France,
Germany, Japan, the Netherlands, Taiwan and the United States. Comparing
estimates across countries reveals three principal findings. First, medical
spending in the calendar year of death accounts for 5–10 per cent of aggregate
medical spending for the whole population and 9–20 per cent for those aged
65 and over. Spending in Taiwan is a little higher, at 16 per cent for the whole
population and 29 per cent for the over-65s. Second, there is a mostly negative
correlation between patient income and medical spending within all countries,
except Japan and Taiwan for the over-65s and Taiwan and the US for the
under-25s. Third, medical spending in all countries is concentrated in a small
share of the population and is persistent over time, although the degree of
concentration and persistence varies across countries.
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Policy points
 Medical spending on those in the last year of life is costly, and accounts
for 5–10 per cent of total medical spending. This cost is not trivial but is
smaller than figures that have been suggested in the past.
 The (mostly) negative correlation between income and medical spending
within all countries suggests that medical systems typically act to
redistribute resources from the rich to the poor. Changes in medical
coverage and provision may therefore have distributional consequences.
 Perhaps surprisingly, the United States is not an outlier in patterns of
individual-level medical spending in the same way that it is in levels
of spending as a share of GDP. Health care spending is somewhat less
concentrated in the US than in most countries, and is less concentrated at
the end of life than in most countries.
I. Introduction
There are significant differences in how health services are financed and
provided across the developed world. Yet relatively little is known about how
these differences in health care funding affect how patterns of spending vary
across countries. Documenting and understanding these differences has the
potential to help explain variation in patient outcomes and aggregate spending
levels and to inform policymakers about possible methods of improving the
efficiency and cost effectiveness of their own health care systems.
This project measures patterns of individual-level spending across
countries, from the patient upwards, using medical records made available
by governments and insurers. In particular, we examine who receives health
care and when they receive it. This is not the first project to attempt to address
these questions,1 but it is novel on several dimensions. First, whereas previous
cross-country projects used only cross-sectional data, our project exploits data
sets that track the same people over many years. This allows us to better
understand medical spending from a lifetime perspective. Second, we use
much better measures of medical spending. Much previous work was based
mostly on survey data, using measures such as whether a respondent went
to see a doctor. Our project includes high-quality administrative data on total
spending from a variety of sources. Total spending likely provides a better
measure of the intensity and quality of care.
The project contributes to three sets of literature. First, we complement the
extensive literature on cross-country variation of aggregate spending. Second,
we contribute to older cross-country work that focused on inequalities in health
1See, for example, van Doorslaer et al. (1997).
C© 2016 The Authors. Fiscal Studies by John Wiley & Sons Ltd. on behalf of Institute for Fiscal Studies
Medical spending around the developed world 329
care spending using less detailed survey data.2 Finally, we add to the literature
on end-of-life care in individual countries.3,4
This project brings together research from nine different countries: Canada
(in particular, the province of Quebec), Denmark, England, France, Germany,
Japan, the Netherlands, Taiwan and the US. As much as is possible, we use
standardisedmethodology and treatment of data to document a set of consistent
measures for all countries.
The rest of this paper is organised as follows. Section II describes the
institutional arrangements and data for each country. Section III presents a
summary of the cross-country results. Section IV concludes.
II. Institutions and measurement
In this section, we document the institutional environment and the data for
the different countries within our study. Previous international comparisons of
health care have mostly relied on either aggregate data or survey-level data.
The main advantage of these aggregate data is that they capture all types of
spending. Figure 1 shows health care spending as a share of GDP in 2012
for all the countries considered in this special issue. As is well documented,
health care is a much larger share of GDP in the US (16 per cent) than in
most other developed countries (typically 8–11 per cent).5 Given that GDP per
head is higher in the US than in all the other countries in our project, these
differences are even larger in terms of levels of spending per person. However,
what aggregate data are unable to capture is the distribution of spending across
the population. A previous literature has attempted to address distributional
questions using surveys that ask individuals about their medical use, but these
surveys suffer from significant measurement issues. Difficulties in measuring
spending are likely to be particularly severe for health care, where individuals
may lack information about the full cost of their care as most of the costs are
not borne by them. Thus, previous survey-based comparisons largely relied
on relatively crude measures of health care consumption such as whether
the respondent saw a doctor in the last year.6 Furthermore, most surveys
capture the responses only of those who are not in a hospital or residential
care. We capture all hospital expenditures and often also spending on other
forms of care, including long-term care both at home and in institutional
settings.
2Van Doorslaer et al., 1997.
3Bekelman et al., 2016.
4See alsoWagstaff et al. (1999) and Stabile and Thomson (2014) for some of the financing issues involved
in medical care and Campbell, Ikegami and Gibson (2010) for international issues related to long-term care.
5OECD, 2014.
6Wagstaff and van Doorslaer, 2000.
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FIGURE 1
Health care as a percentage of GDP, 2012
∗Figure for England is not available, so we use the UK figure.
Note: Figure for Taiwan is for 2013.
Source: OECD, 2014; Chen and Chuang, this issue.
The papers in this study utilise administrative data used for paying providers
of health care. These data give much more complete information about
spending at an individual level. Most of the countries in this project have
national health care systems. Because these national systems compensate
hospitals and other providers based on care provided, we can measure who
receives the benefits. In other countries, such as Germany, Japan and the US,
we have data on private providers. These allow us to measure individual-
level costs, since insurers pay providers based on individuals’ expenditures.
Although the details of data collection vary from country to country, we
have extremely high-quality measures of medical care spending for all
countries.
By focusing on the total cost of health care, rather than a specific disease or
setting, we are able to provide evidence to inform the public debates around
how to contain health care costs and we can draw general conclusions that
are not limited to specific, and potentially unrepresentative, conditions. In all
countries, we have information on hospitals, which account for the majority
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of health care costs. For a subset of countries, we also have data on long-term
care (LTC), which we will also refer to as social care and nursing homes.
Table 1 summarises the financing and provider institutions for both health
care and LTC for the countries in this issue. When comparing the different
countries, it is clear that there is no one-to-one mapping between how health
care services are funded and how they are provided or between health care and
LTC.
With some exceptions, US health care is privately provided. Most US
hospitals are run either by non-profit institutions such as universities and
religious organisations or by private for-profit companies. The majority of
health care for those under 65 is funded through private health insurance,
which individuals receive via their employer. The public sector provides
insurance through two federal social insurance programmes –Medicaid, which
covers low-income families with children (and some childless adults also)
and low-income disabled people, and Medicare, which covers relatively high-
income disabled and elderly individuals. The introduction of the Affordable
Care Act, or ‘Obamacare’, in 2010 has expanded the government’s role
in the health care sector, increasing both Medicaid coverage and private
coverage.
After the age of 65, Medicare provides health insurance to almost all. This
near-universal insurance is not means tested and brings the US health care
system nearer to many other systems in the OECD. Medicare pays for the
majority of the cost of short-term hospital stays and doctor visits and, since
2006,most of the costs associatedwith pharmaceuticals. However,Medicare in
general does not pay for nursing home stays. These costs are paid out-of-pocket
or by Medicaid, where payments are means tested.
The project provides four studies from the US. This is because no one
data set captures all the features of medical spending we wish to capture
for the US, in large part because there are multiple payers for medical care.
Pashchenko and Porapakkarm employ the Medical Expenditure Panel Survey
(MEPS), which is a representative sample of the US population. Individual
survey responses are linked to provider information. Thus, the survey has high-
quality information on medical spending. However, it only has information
over a two-year span and it lacks information on nursing home expenditures.
To circumvent these problems for the US, we have one study (Hirth et al.)
that employs administrative private insurance data with a long panel and
another study (Fahle, McGarry and Skinner) that uses a long panel of self-
reported out-of-pocket medical spending – the Health and Retirement Study
– which includes information on those who die and enter nursing homes, for
the population aged 50 and over. These studies show that those with high
spending in one year have high spending many years in the future. We also
have one study (De Nardi et al.) that uses a data set – the Medicare Current
C© 2016 The Authors. Fiscal Studies by John Wiley & Sons Ltd. on behalf of Institute for Fiscal Studies
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Beneficiary Study – that measures total medical spending, including nursing
home spending, for the population aged 65 and over.7
Denmark (Christensen, Gørtz and Kallestrup-Lamb) and England (Arago´n,
Chalkley and Rice; Kelly, Stoye and Vera-Herna´ndez) both have health care
systems where the majority of health care is funded through taxation and
provided by the public sector. The main difference between the countries is
in long-term care, which is mostly public in Denmark but largely privately
funded and provided in England. The Danish register provides detailed data
on primary, secondary and long-term care. By contrast, in England, there are
only detailed data on the use of hospitals (outpatient and inpatient). In the
Canadian province of Quebec (Coˆte´-Sergent, E´chevin and Michaud), health
care is funded through taxation, but providers are privately owned.
A final group of countries finance health care through mandatory insurance,
including France (Gastaldi-Me´nager, Geoffard and de Lagasnerie), Germany
(Karlsson, Klein and Ziebarth), Japan (Ibuka et al.), the Netherlands (Bakx,
O’Donnell and vanDoorslaer) andTaiwan (Chen andChuang). These countries
vary in the extents to which the public sector provides insurance plans and to
which it provides services. In theNetherlands, all hospitals are private, whereas
the majority of hospitals in France are publicly owned.
Almost all countries provide nationally representative data. The exceptions
are Germany and Japan, with each relying on data from an individual insurance
company; the data are therefore not fully representative, but are highly accurate
and include many types of care. This should be taken into account when
interpreting results.
In addition to the individual country studies, which aim to provide a
common set of descriptive facts, we have a further two papers that concentrate
on related issues. The first (Banks, Keynes and Smith) is a study of health,
disability and mortality differences between the US and England for the
population aged 50 and over. The data sets used – the Health and Retirement
Study for the US and the English Longitudinal Study of Ageing for England –
are structured in extremely similar fashions, making health measures directly
comparable across the US and England. Given the differences in the way the
health care systems are financed and delivered, this provides a useful context
for understanding differences in the distribution of health care spending. Banks
et al. find higher disease prevalence in the US than in England (confirming
previous findings) but much smaller differences between the two countries in
disability and mortality. The second additional paper (Cookson et al.) provides
a detailed literature review of work on inequalities in health care provision and
use in England. The authors show that although the poor consume more health
care resources than the rich (because they suffermore illness), the rich consume
better-quality care and achieve better health outcomes. The implications could
7See also Evans and Humpherys (2015) for an analysis of monthly patterns of medical spending.
C© 2016 The Authors. Fiscal Studies by John Wiley & Sons Ltd. on behalf of Institute for Fiscal Studies
Medical spending around the developed world 337
extend beyond England, and the paper provides important background for the
socio-economic variation in spending that we document.
III. Findings
1. Correlation with income
Table 2 presents the ratio of average spending in the richest fifth of the income
distribution to average spending in the poorest fifth. It shows that there is a
mostly negative correlation between income and medical spending within all
countries. There is already an extensive literature that examines inequalities
TABLE 2
Ratio of mean spending in richest quintile to mean spending in poorest quintile
All medical care,
including long-term
care
All medical care,
excluding long-term
care
Hospital care
Aged 0–24
Denmark
England 0.819
Japan 0.900 0.766
Netherlands 0.531 0.742 0.897
Taiwan 1.154 1.127
United States 1.306 0.777
Aged 25–64
Denmark 0.409 0.445 0.406
England 0.794
Japan 0.362 0.304
Netherlands 0.310 0.563 0.725
Taiwan 0.963 0.941
United States 0.884 0.730
Aged 65 and over
Denmark 0.398 0.571 0.522
England 0.740
Japan 1.165 1.276
Netherlands 0.496 0.759 0.814
Taiwan 1.425 1.239
United Statesa 0.876 0.774
United Statesb 0.714 0.908 0.739
aThe numbers shown differ from those in Pashchenko and Porapakkarm (this issue) because of the treatment
of income.
bDe Nardi et al., this issue.
Note: France, Germany and Quebec are unable to disaggregate spending by income. Medical spending for
Taiwan derives from Figure 7 of Chen and Chuang (this issue).
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(not controlling for need) and inequities (controlling for need) in access to
and use of health care by income. We contribute to this literature by using
far more comprehensive measures of health care spending. We show that,
with the exception of those aged 65 and over in both Japan and Taiwan as
well as those under 25 in both Taiwan and the US, people in the bottom fifth
of the income distribution consume more medical care than those in the top
fifth. This is consistent with the evidence that low-income individuals are less
healthy than high-income individuals.8 As we are unable to control for need,
we make no claims about whether or not this is an equitable distribution.
Instead, we note that those at the bottom of the income distribution consume a
larger amount of care, signifying that health care systems in most countries act
to redistribute resources from rich to poor. Interestingly, the three countries
where income and medical spending are positively related include a country
that has a largely private care system (the US) and a country that uses patient
cost-sharing (Taiwan).
This correlation between income and medical spending changes little over
the life cycle on average. Different countries have different patterns, but there
is little in the way of systematic patterns across countries. Perhaps the most
dramatic pattern we observe is in the US, where before age 25 there is a
positive relationship and afterwards it turns negative. Ozkan (2015) argues
that this positive correlation between family income and medical spending
is an important driver of health inequality between high- and low-income
people later in life in the US. Interestingly, although income and health appear
positively correlated in all countries, this correlation between income and self-
reported health is greater in the US than in most European countries.9
Medical spending and income are especially negatively correlated when
using the most complete measure of medical spending, including LTC. For
many countries, we only have access to data on hospital spending. However,
for the countries where we have more comprehensive measures of health care
use, we calculate the relationship between income and different measures
of health care spending, including LTC (which we have for Denmark, the
Netherlands and the US). For example, among those aged 65 and over in
the Netherlands, spending on the top quintile of the income distribution is
81 per cent of spending on the bottom quintile when using hospital medical
spending, but only 50 per cent that of the bottom quintile when using the
total including LTC. Similarly, in the US, the numbers are 74 per cent when
using hospital spending and 71 per cent when using total. Long-term care is
used heavily amongst those with low incomes in the countries where we can
measure spending on nursing homes.
8See Case, Lubotsky and Paxson (2002) and the references therein for the income health gradient at
younger ages and De Nardi, French and Jones (2013) for the income health gradient for older ages in the
US.
9Van Doorslaer et al., 1997; Smith, 2004; O’Donnell, van Doorslaer and van Ourti, 2014.
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2. Concentration and persistence
The concentration of medical spending is high in all countries, reflecting the
distribution of severe episodes of ill health, but the extent of the concentration
does vary. In the US, between 50 and 70 per cent of all medical spending goes
to the top 10 per cent of all spenders, regardless of whether long-term care
is included or excluded. This is similar to the range for France. In Denmark,
Japan and the Netherlands, estimates range from 65 to 80 per cent. It is likely
that at least part of this variation reflects differences in the composition of
spending available in the data. Even so, this evidence does not seem to support
the assertionsmade by someUS commentators that the US is an outlier and that
the high concentration is a feature of the structure of the health care system.
Medical spending is highly persistent in all countries.10 High medical
spending in one year strongly predicts high medical spending in the following
year. For most countries, the probability of being in the top spending quintile in
a given year conditional on being in the top spending quintile in the previous
year is approximately 50 per cent. Persistence in health spending is high
because persistence in health is high. However, judging a health care system
based on persistence is difficult because good care (keeping people alive longer)
and bad care (failing to diagnose correctly) could both increase persistence.
3. The cost of end-of-life care
Health care spending in the last year of life has been a focus for both
policymakers and the academic literature since at least the 1980s, for a number
of reasons. First, at least since Scitovsky (1984), analysts have noted – and
some have decried – the high cost of dying. This has prompted calls for
issuing advance directives on the patient’s side, where patients would list their
preferences for end-of-life care in advance of life-threatening conditions.11
It has also prompted calls for greater use of hospice and home care instead
of expensive medical treatment. Finally, it has prompted calls for greater cost
control on the provider’s side, where hospitals would be issued with guidelines
to identify and reduce futile care. Different countries have tried to use different
approaches. All of these approaches have proven highly controversial. For
example, the recent Affordable Care Act (or Obamacare) in the US initially
included provisions to identify and eliminate futile care. These provisions
were decried as ‘death panels’ and were removed from the final version of the
Affordable Care Act. In the UK, the National Institute for Health and Care
Excellence (NICE) provides guidelines for health care. These guidelines have
certain similarities to the provisions eliminated from the Affordable Care Act.
10This is not the case in Quebec.
11Murphy and Finucane, 1993.
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Another motivation for better understanding the cost of end-of-life care
is to help forecast future medical spending. An important part of forecasting
futuremedical spending is forecastingmedical spending at older ages, since the
elderly spend more on health care than other age groups, and thus population
ageing is potentially an important driver of future medical spending. Some
have argued that the potential cost of population ageing will not be as big as
some others expect, since a major cost of ageing is the cost of dying – incurred
in the last year or few months of life – not the cost of being older per se. As
people die only once, projecting health care spending based on the age profile
of the population therefore overstates the impact of population ageing. This
is sometimes known as the red herring hypothesis, as introduced by Zweifel,
Felder and Meiers (1999). Most subsequent papers, across many different
countries and settings, provide varying degrees of support for the hypothesis.
The evidence tends to be stronger for medical care than for long-term care.12
While papers on the red herring hypothesis may differ on the relative
importance of ageing and time to death, all work shows that death is expensive
and that health care costs increase in the months before death. Nevertheless,
there is still a debate on the share of aggregate health care spending that is spent
on the last year of people’s lives. Twenty years ago, Emanuel and Emanuel
(1994) calculated that only about 10 per cent of USmedical spending was from
the year of death and thus cost savings from reducing end-of-life care would
be modest. However, little follow-up evidence has emerged in the intervening
period. Although there have been multiple studies of, for example, the US
Medicare’s expenditures in the last year of life, for certain segments of the
population, there has not been a systematic estimate of the end of life’s share
of US health expenditures as a whole. Polder, Barendregt and van Oers (2006)
estimate that the share is 11.1 per cent for the Netherlands but speculate that it
may be higher for the US. Aldridge and Kelley (2015) estimate that spending
in the last year of life is responsible for 13 per cent of US medical spending,
although this estimate relies on imputation for many of the payers for health
care and some service types.
To address this gap in the evidence on end-of-life care, we consider health
care and LTC in the last year of life for countries where the data are available.
Recently, Bekelman et al. (2016) measured end-of-life spending for cancer
patients across a number of countries. They showed that, perhaps surprisingly,
a smaller proportion die from cancer in acute care hospitals in the US and the
Netherlands than in other countries. We build insights relative to that paper in
the following dimensions. First, whereas Bekelman et al. showed only results
for the cost of hospital stays, we have a more comprehensive measure of health
care spending for most countries. We show that LTC usage before death varies
greatly across countries. Second, we consider all conditions, not just cancer.
12Karlsson and Klohn, 2014.
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TABLE 3
Spending on those in the last calendar year of life as a share of aggregate spending
All medical care,
including long-term
care
All medical care,
excluding long-term
care
Hospital care
Aged 65 and over
Denmark 0.141 0.153 0.080
England 0.196
France 0.103
Japan 0.168
Netherlands 0.102 0.093 0.112
Taiwan 0.288
United States 0.105 0.093 0.149
All
Denmark 0.083 0.082 0.052
England 0.104
France 0.056
Germany 0.079
Japan 0.107
Netherlands 0.056 0.044 0.059
Quebec 0.113
Taiwan 0.159
United States 0.049 0.039 0.068
Note: Spending is as a share of spending in that category and for that age group. For example, hospital care
spending for those aged 65 and over is hospital spending of those aged 65 and over in the last calendar year
of life divided by total hospital spending of everyone aged 65 and over in that country.
Third, wemeasure the share of aggregate health care expenditure going to those
in the calendar year of death, and thus use a measure of usage that is invariant
to how we handle the price of medical care, which makes our cross-country
comparisons easier to understand.
The results in Table 3 suggest that medical spending in the calendar year of
death accounts for approximately 5–10 per cent of aggregate medical spending
in most countries. There is no strong link between this percentage and the type
of health care system. The US is not an outlier on share of spending. For
example, medical spending in the last year of life represents 5 per cent of
aggregate medical spending in the US, 6 per cent in the Netherlands and
8 per cent in Denmark. However, the much higher level of total spending in
the US means that the average cost of the last year of life is higher than in
most other countries. The US spends more on health care for all age groups
and stages of life, including the last year of life. But it is certainly not the case
that medical care is more concentrated in the last year of life in the US than in
other countries.
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Dying is expensive in all countries. However, given that it represents less
than 10 per cent of total medical spending in most countries, cost savings from
reducing end-of-life care will be modest. One important caveat that we should
note is that while spending in the year of death is not extremely high, the cost
of death in the two years prior is still very high. This fact is shown in some of
the particular country studies. For example, in the US, 5 per cent of aggregate
spending is in the last year of life but 13 per cent is in the last three years of
life.
A key determinant of cross-country differences in the share of health care
spending in the last year of life is attributable to long-term care. For example,
in the Netherlands, approximately half of the spending at the end of life is
attributable to LTC. When using a narrower definition of medical care that
excludes LTC, we can obtain measures of medical spending prior to death for
more countries. For example, using this narrower measure shows that end-of-
life expenditures represent 4 per cent of non-LTC spending for the Netherlands
and the US, 6 per cent for France, 8 per cent for Denmark and Germany, and
11 per cent for Japan. For countries using just hospital spending, the numbers
are 5 per cent for Denmark, 6 per cent for the Netherlands, 7 per cent for
the US, 10 per cent for England, 11 per cent for Quebec and 16 per cent
for Taiwan. In summary, the US is in no way a high-spending country for
end-of-life care as a share of aggregate medical spending. In fact, it is the
east Asian countries where end-of-life spending represents the highest share
of total medical spending.
IV. Conclusions
This paper summarises themain findings of the nine-country project examining
patterns of medical spending in the developed world. Taking all of the results
together, the project reveals three principal findings. First, medical spending
is almost always negatively correlated with income. This indicates that most
health care systems act to redistribute resources from rich to poor. Second,
medical spending in all countries is concentrated and very persistent, in large
part reflecting patterns of underlying health. Finally, spending on those in
the final year of life amounts to between 5 and 10 per cent of all medical
spending in most countries. This is a significant share of total spending, but
does show that reducing end-of-life spending would result in a very modest
change in spending overall. In each of these respects, the US health care system
is not an outlier in the same way that it appears to be in the level of overall
spending.
Each paper in this special issue provides further details on the institutions
and data available in each country and presents a core set of common results.
Each can be read standalone or be used to make comparisons across countries.
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